Cornea۲۰۲۵نمایه شده در PubMed
Luis C Barrientos, Ryan Frisbie, Jennifer L Jung, Lauren Mehner, Casey Smith, Rebecca G Edwards Mayhew, Ronald Wise, Emily A McCourt, Michael A Puente
چکیده
Down syndrome is one of the strongest risk factors of keratoconus. Corneal collagen crosslinking (CXL) is the standard-of-care treatment to reduce progression, but there is limited published literature about CXL in patients with Down syndrome. We sought to describe outcomes of epithelium-off CXL…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1097/ico.0000000000003881